Pinolenic acid

CAS No. 16833-54-8

Pinolenic acid( ——— )

Catalog No. M38666 CAS No. 16833-54-8

Pinolenic acid (PNLA) is a polyunsaturated fatty acid that can be isolated from Pinus orientalis and Pinus pinaster seed oil. Pinolenic acid has anti-inflammatory and lipid-lowering activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 153 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Pinolenic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Pinolenic acid (PNLA) is a polyunsaturated fatty acid that can be isolated from Pinus orientalis and Pinus pinaster seed oil. Pinolenic acid has anti-inflammatory and lipid-lowering activities.
  • Description
    Pinolenic acid (PNLA) is a polyunsaturated fatty acid that can be isolated from Pinus orientalis and Pinus pinaster seed oil. Pinolenic acid has anti-inflammatory and lipid-lowering activities.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    16833-54-8
  • Formula Weight
    278.43
  • Molecular Formula
    C18H30O2
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    C(C/C=C\C/C=C\CCCCC)/C=C\CCCC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Takala R, et al. The Beneficial Effects of Pine Nuts and Its Major Fatty Acid, Pinolenic Acid, on Inflammation and Metabolic Perturbations in Inflammatory Disorders. Int J Mol Sci. 2023 Jan 6;24(2):1171.?
molnova catalog
related products
  • bryonamide A

    Bryonamide A is a natural compound isolated from red algae Bostrychia radicans (Rhodomelaceae).

  • Olokizumab

    Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting interleukin-6 (IL-6), primarily used in rheumatoid arthritis (RA) research .

  • MS37452

    MS37452 is a competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43 μM).